ECSTRRA

Impact of conventional and biological disease-modifying anti-rheumatic drugs on arterial lesions in Takayasu arteritis

2024-07-06

Diego Bletry, Louis Meyblum, Kristell Desseaux, Mathieu Vautier, Laurent Chiche, Alexandre Le Joncour et al.

Rheumatology (Oxford, England)

View on PubMed

A retrospective observational study of ibrutinib in chronic lymphocytic leukaemia in a real-life setting in France using the national claims database (OSIRIS)

2024-07-04

Sylvain Choquet, Clarisse Marchal, Floriane Deygas, Marine Deslandes, Nahid Macher, Gérard de Pouvourville, et al.

Annals of hematology

View on PubMed

New Insights Into the Therapeutic Management of Varicella Zoster Virus Meningitis: A Series of 123 Polymerase Chain Reaction-Confirmed Cases

2024-07-03

Marie Dulin, Sylvie Chevret, Maud Salmona, Hervé Jacquier, Béatrice Bercot, Jean-Michel Molina, et al.

Open forum infectious diseases

View on PubMed

Risk factors and outcome associated with fungal infections in patients with severe burn injury: 10-year retrospective IFI-BURN study

2024-06-25

Emmanuel Dudoignon, Sylvie Chevret, Sorel Tsague, Samia Hamane, Marc Chaouat, Benoit Plaud et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

View on PubMed

Difference in Restricted Mean Survival Times as a Measure of Effect Size: No Assumption Does Not Mean No Rule

2024-06-24

Paul de Boissieu, Sylvie Chevret

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

View on PubMed

Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages

2024-06-19

Jean-Sélim Driouich, Maxime Cochin, Guillaume Lingas, Léa Luciani, Cécile Baronti, Ornéllie Bernadin, Ma et al.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

View on PubMed

Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial

2024-06-18

Philippe Moreau, Cyrille Hulin, Aurore Perrot, Bertrand Arnulf, Karim Belhadj, Lotfi Benboubker et al.

The Lancet. Oncology

View on PubMed

Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study

2024-06-13

Pierre Hirsch, Jérôme Lambert, Maxime Bucci, Caroline Deswarte, Augustin Boudry, Juliette Lambert, et al.

Blood cancer journal

View on PubMed

Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections: A Review

2024-06-12

Romain Pirracchio, Balasubramanian Venkatesh, Matthieu Legrand

JAMA

View on PubMed

Prospective comparison of cytomegalovirus quantification in whole blood and plasma samples among hematopoietic stem cell transplant and kidney transplant recipients

2024-06-09

Marion Helary, Nathalie Schnepf, Nadia Mahjoub, Mathilde Lacroix, Alienor Xhaard, Gillian Divard et al.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

View on PubMed

NGS-based stratification refines the risk stratification in T-ALL and identifies a Very High-Risk subgroup of patients

2024-06-07

Mathieu Simonin, Loic Vasseur, Etienne Lengliné, Ludovic Lhermitte, Aurelie Cabannes-Hamy, Marie Balsat, et al.

Blood

View on PubMed

Two-stage randomized clinical trials with a right-censored endpoint: Comparison of frequentist and Bayesian adaptive designs

2024-06-06

Luana Boumendil, Sylvie Chevret, Vincent Lévy, Lucie Biard

Statistics in medicine

View on PubMed

Immunomodulatory effects of single and combined exposure to ZnO and TiO2 nanoparticles on rainbow trout challenged with Aeromonas salmonicida achromogenes

2024-06-06

Mahaut Beghin, Jérôme Lambert, Joachim Sturve, Valérie Cornet, Patrick Kestemont

Aquatic toxicology (Amsterdam, Netherlands)

View on PubMed

A deep learning approach for generating intracranial pressure waveforms from extracranial signals routinely measured in the intensive care unit

2024-06-04

Shiker S Nair, Alina Guo, Joseph Boen, Ataes Aggarwal, Ojas Chahal, Arushi Tandon et al.

Computers in biology and medicine

View on PubMed

Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial

2024-06-03

Xavier Leleu, Cyrille Hulin, Jerome Lambert, Arthur Bobin, Aurore Perrot, Lionel Karlin et al.

Nature medicine

View on PubMed

Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 switching to long-acting cabotegravir and rilpivirine

2024-05-30

Emma Rubenstein, Myriam Diemer, Lauriane Goldwirt, Caroline Lascoux-Combe, Marie-Laure Chaix, Agathe Rami et al.

AIDS (London, England)

View on PubMed

Evaluating the toxicity of estetrol, 17α-ethinylestradiol, and their combination with drospirenone on zebrafish larvae: A behavioural and proteomic study

2024-05-09

Sébastien Baekelandt, Nathalie Leroux, Jérôme Lambert, Benoît Bernay, Jean-Baptiste Robert, Laura Burattin, Cé et al.

Aquatic toxicology (Amsterdam, Netherlands)

View on PubMed

Increased levels of GM-CSF and CXCL10 and low CD8+ memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older people

2024-05-07

Johanne Poisson, Carine El-Sissy, Arnaud Serret-Larmande, Nikaïa Smith, Morgane Lebraud, Jean-Loup Augy, et al.

Immunity & ageing : I & A

View on PubMed

Down to size: Exploring the influence of plastic particle Dimensions on physiological and nervous responses in early-stage zebrafish

2024-05-04

Mathilde J L Oger, Océane Vermeulen, Jérôme Lambert, Thomas L Madanu, Patrick Kestemont, Valérie Cornet

Environmental pollution (Barking, Essex : 1987)

View on PubMed

Air leak test in the Paediatric Intensive Care Unit (ALTIPICU): rationale and protocol for a prospective multicentre observational study

2024-04-30

Boris Lacarra, Aurélie Hayotte, Jérôme Naudin, Arielle Maroni, Guillaume Geslain, Géraldine Poncelet, Mi et al.

BMJ open

View on PubMed

Estetrol/drospirenone versus 17α-ethinylestradiol/drospirenone: An extended one generation test to evaluate the endocrine disruption potential on zebrafish (Danio rerio)

2024-04-28

Sébastien Baekelandt, Antoine Bouchat, Nathalie Leroux, Jean-Baptiste Robert, Laura Burattin, Emmanuel Cishibanji, et al.

Environment international

View on PubMed

Composite event-free-survival as an endpoint in oncology drug evaluation: Review and guidance perspectives from the Haute Autorité de Santé (HAS)

2024-04-23

Etienne Lengliné, Joachim Baba, Paul de Boissieu, Alexandre Beaufils, Alice Desbiolles, Thierno Diatta, et al.

European journal of cancer (Oxford, England : 1990)

View on PubMed

What Clinicians Should Know About Surrogate Endpoints in Hematologic Malignancies

2024-04-11

Côme Bommier, Matthew John Maurer, Jerome Lambert

Blood

View on PubMed

Dose optimization for cancer treatments with considerations for late-onset toxicities

2024-04-09

Lucie Biard, Anaïs Andrillon, Rebecca B Silva, Shing M Lee

Clinical trials (London, England)

View on PubMed

Publications

Impact of conventional and biological disease-modifying anti-rheumatic drugs on arterial lesions in Takayasu arteritis

A retrospective observational study of ibrutinib in chronic lymphocytic leukaemia in a real-life setting in France using the national claims database (OSIRIS)

New Insights Into the Therapeutic Management of Varicella Zoster Virus Meningitis: A Series of 123 Polymerase Chain Reaction-Confirmed Cases

Risk factors and outcome associated with fungal infections in patients with severe burn injury: 10-year retrospective IFI-BURN study

Difference in Restricted Mean Survival Times as a Measure of Effect Size: No Assumption Does Not Mean No Rule

Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages

Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial

Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study

Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections: A Review

Prospective comparison of cytomegalovirus quantification in whole blood and plasma samples among hematopoietic stem cell transplant and kidney transplant recipients

NGS-based stratification refines the risk stratification in T-ALL and identifies a Very High-Risk subgroup of patients

Two-stage randomized clinical trials with a right-censored endpoint: Comparison of frequentist and Bayesian adaptive designs

Immunomodulatory effects of single and combined exposure to ZnO and TiO2 nanoparticles on rainbow trout challenged with Aeromonas salmonicida achromogenes

A deep learning approach for generating intracranial pressure waveforms from extracranial signals routinely measured in the intensive care unit

Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial

Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 switching to long-acting cabotegravir and rilpivirine

Evaluating the toxicity of estetrol, 17α-ethinylestradiol, and their combination with drospirenone on zebrafish larvae: A behavioural and proteomic study

Increased levels of GM-CSF and CXCL10 and low CD8+ memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older people

Down to size: Exploring the influence of plastic particle Dimensions on physiological and nervous responses in early-stage zebrafish

Air leak test in the Paediatric Intensive Care Unit (ALTIPICU): rationale and protocol for a prospective multicentre observational study

Estetrol/drospirenone versus 17α-ethinylestradiol/drospirenone: An extended one generation test to evaluate the endocrine disruption potential on zebrafish (Danio rerio)

Composite event-free-survival as an endpoint in oncology drug evaluation: Review and guidance perspectives from the Haute Autorité de Santé (HAS)

What Clinicians Should Know About Surrogate Endpoints in Hematologic Malignancies

Dose optimization for cancer treatments with considerations for late-onset toxicities